Prem Puri

ORCID: 0000-0003-4964-0095
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Congenital gastrointestinal and neural anomalies
  • Pediatric Urology and Nephrology Studies
  • Urological Disorders and Treatments
  • Liver Disease Diagnosis and Treatment
  • Intestinal Malrotation and Obstruction Disorders
  • Muscle Physiology and Disorders
  • Congenital Diaphragmatic Hernia Studies
  • Liver Disease and Transplantation
  • Ureteral procedures and complications
  • Gastrointestinal motility and disorders
  • Gastroesophageal reflux and treatments
  • Congenital Anomalies and Fetal Surgery
  • Esophageal and GI Pathology
  • Neonatal Respiratory Health Research
  • Urinary Bladder and Prostate Research
  • Histone Deacetylase Inhibitors Research
  • Renal and related cancers
  • Diet, Metabolism, and Disease
  • Gastrointestinal disorders and treatments
  • Pelvic floor disorders treatments
  • Tracheal and airway disorders
  • Ubiquitin and proteasome pathways
  • Congenital heart defects research
  • Adipose Tissue and Metabolism
  • Cancer-related Molecular Pathways

Virginia Commonwealth University Medical Center
2006-2025

Hunter Holmes McGuire VA Medical Center
2014-2025

Virginia Commonwealth University
2014-2025

Sanford Burnham Prebys Medical Discovery Institute
2015-2024

University College Dublin
2015-2024

Discovery Institute
2015-2024

Amity University
2024

Veterans Health Administration
2023

University Health System
2006-2022

Children's Health Ireland at Crumlin
2012-2021

Abstract The spectrum of nonalcoholic fatty liver disease (NAFLD) includes a (NAFL) and steatohepatitis (NASH). specific types amounts lipids that accumulate in NAFLD are not fully defined. free acid (FFA), diacylglycerol (DAG), triacylglycerol (TAG), cholesterol (FC), ester, phospholipid contents normal livers were quantified compared to those NAFL NASH, the distribution acids within these classes was across groups. Hepatic by capillary gas chromatography. mean (nmol/g tissue) DAG...

10.1002/hep.21763 article EN Hepatology 2007-07-25

The expression of microRNA in nonalcoholic steatohepatitis (NASH) and their role the genesis NASH are not known. aims this study were to: (1) identify differentially expressed microRNAs human NASH, (2) tabulate potential targets, (3) define effect a specific microRNA, miR-122, on its targets compare these effects with pattern NASH. 474 was compared subjects metabolic syndrome versus controls normal liver histology. Differentially identified by muParaflo microarray assay validated using...

10.1002/hep.22569 article EN Hepatology 2008-08-05

Specific alterations in hepatic lipid composition characterize the spectrum of nonalcoholic fatty liver disease (NAFLD), which extends from (NAFL) to steatohepatitis (NASH). However, plasma lipidome NAFLD and whether NASH has a distinct lipidomic signature are unknown. A comprehensive analysis lipids eicosanoid metabolites quantified by mass spectrometry was performed NAFL (n = 25) 50) subjects compared with lean normal controls 50). The key findings include significantly increased total...

10.1002/hep.23229 article EN Hepatology 2009-08-10

The extracellular signals which regulate the myogenic program are transduced to nucleus by mitogen-activated protein kinases (MAPKs). We have investigated role of two MAPKs, p38 and signal-regulated kinase (ERK), whose activities undergo significant changes during muscle differentiation. is rapidly activated in myocytes induced differentiate. This activation differs from those triggered stress cytokines, because it not linked Jun–N-terminal stimulation maintained whole process myotube...

10.1128/mcb.20.11.3951-3964.2000 article EN Molecular and Cellular Biology 2000-06-01

Thirteen girls with grade III-V vesicoureteric reflux were treated by endoscopic injection of Teflon paste behind the intravesical ureter. Fourteen 18 ureters showed complete absence after one Teflon. Three required a second for successful treatment reflux. One ureter IV was converted to II Properly carried out, this procedure corrects It takes less than 15 minutes, may be done as day procedure, and avoids open surgery. There have been no complications.

10.1136/bmj.289.6436.7 article EN BMJ 1984-07-07

The histologic spectrum of nonalcoholic fatty liver disease (NAFLD) includes (NAFL) and steatohepatitis (NASH), which can progress to cirrhosis in up 20% NASH patients. Bile acids (BA) are linked the pathogenesis therapy NASH. We (1) characterized plasma BA profile biopsy‐proven NAFL compared controls (2) related features, activity, fibrosis. Liquid chromatography/mass spectrometry quantified BAs. Descriptive statistics, paired multiple group comparisons, regression analyses were performed....

10.1002/hep.29359 article EN Hepatology 2017-07-11

OBJECTIVES: Cirrhosis and hepatic encephalopathy (HE) can adversely affect survival, but their effect on socioeconomic emotional burden the family is not clear. The aim was to study of cirrhosis HE patients informal caregivers. METHODS: A cross-sectional in two transplant centers (Veterans University) cirrhotic caregivers performed. Demographics for patient/caregivers, model-for-end-stage liver disease (MELD) score, complications were recorded. Patients underwent a cognitive battery,...

10.1038/ajg.2011.157 article EN The American Journal of Gastroenterology 2011-05-10

Summary Background Safety of individual probiotic strains approved under Investigational New Drug ( IND ) policies in cirrhosis with minimal hepatic encephalopathy MHE is not clear. Aim The primary aim this phase I study was to evaluate the safety, tolerability Lactobacillus GG LGG compared placebo, while secondary ones were explore its mechanism action using cognitive, microbiome, metabolome and endotoxin analysis patients. Methods Cirrhotic patients randomised 1:1 into or placebo BID after...

10.1111/apt.12695 article EN Alimentary Pharmacology & Therapeutics 2014-03-16

Hepatic encephalopathy (HE) can cause major morbidity despite standard of care (SOC; rifaximin/lactulose). Fecal microbial transplant (FMT) enemas postantibiotics are safe, but the effect FMT without antibiotics using capsular route requires investigation. The aim this work was to determine safety, tolerability, and impact on mucosal/stool microbiota brain function in HE after a randomized, single‐blind, placebo‐controlled clinical trial Virginia. Patients with cirrhosis recurrent MELD...

10.1002/hep.30690 article EN Hepatology 2019-05-01
Mohammad Shadab Siddiqui Goro Yamada Raj Vuppalanchi Mark L. Van Natta Rohit Loomba and 95 more Cynthia D. Guy Danielle Brandman James Tonascia Naga Chalasani Brent A. Neuschwander‐Tetri Arun J. Sanyal Daniela Allende Srinivasan Dasarathy Arthur J. McCullough Revathi Penumatsa Jaividhya Dasarathy Joel E. Lavine Manal F. Abdelmalek Mustafa R. Bashir Stephanie Buie Anna Mae Diehl Cynthia D. Guy Christopher Kigongo Mariko Kopping David Malik Dawn Piercy Naga Chalasani Oscar W. Cummings Samer Gawrieh Linda Ragozzino Kumar Sandrasegaran Raj Vuppalanchi Elizabeth M. Brunt Theresa Cattoor Danielle Carpenter Janet Freebersyser Debra King Jinping Lai Brent A. Neuschwander‐Tetri Joan Siegner Susan L. Stewart Susan Torretta Kristina Wriston Maria Cardona Gonzalez Jodie Davila Manan Jhaveri Kris V. Kowdley Nizar A. Mukhtar Erik Ness Michelle Poitevin Brook A. Quist Sherilynn Soo Brandon Ang Cynthia Behling Archana Bhatt Rohit Loomba Michael S. Middleton Claude B. Sirlin Maheen F. Akhter Nathan M. Bass Danielle Brandman Ryan M. Gill Bilal Hameed Jacqueline Maher Norah A. Terrault Ashley Ungermann Matthew M. Yeh Sherry Boyett Melissa J. Contos S. Kirwin Velimir A. Luketic Prem Puri Arun J. Sanyal Jolene Schlosser Mohammad Shadab Siddiqui Leslie Yost-Schomer Elizabeth M. Brunt Kathryn J. Fowler David E. Kleiner Edward Doo Sherry Hall Jay H. Hoofnagle Jessica J. Lee Patricia R. Robuck Averell H. Sherker Rebecca Torrance Patricia Belt Jeanne M. Clark J.A. Dodge Michele Donithan Erin Hallinan Milana Isaacson Mariana Lazo Jill Meinert Laura Miriel Jacqueline Smith Michael L. Smith Jürgen Floege James Tonascia Mark L. Van Natta

10.1016/j.cgh.2018.12.031 article EN publisher-specific-oa Clinical Gastroenterology and Hepatology 2019-01-05

Minimal hepatic encephalopathy (MHE) detection is difficult because of the unavailability short screening tools. Therefore, MHE patients can remain undiagnosed and untreated. The aim this study was to use a Stroop smartphone application (app) (EncephalApp_Stroop) screen for MHE. app standard psychometric tests (SPTs; 2 4 abnormal MHE, gold standard), score (PHES), inhibitory control (ICTs) were administered with cirrhosis (with or without previous overt encephalopathy; OHE) age-matched...

10.1002/hep.26309 article EN Hepatology 2013-02-06

10.1038/s41588-018-0281-y article EN Nature Genetics 2018-12-18

Abstract Fibro-adipogenic progenitors (FAPs) are currently defined by their anatomical position, expression of non-specific membrane-associated proteins, and ability to adopt multiple lineages in vitro. Gene analysis at single-cell level reveals that FAPs undergo dynamic transitions through a spectrum cell states can be identified differential levels Tie2 Vcam1. Different patterns Vcam1-negative high or low /Vcam1-expressing detected during neonatal myogenesis, response acute injury Duchenne...

10.1038/s41467-018-06068-6 article EN cc-by Nature Communications 2018-09-04

Abstract Background and Aims Bile acids are hepatic metabolites have many properties considered to be relevant the pathophysiology of NAFLD. Circulating levels intestinal microbiome‐modified bile acid deoxycholate increased in cirrhosis. Approach Results To further elucidate role microbiota linked progressively severe NAFLD, a multiomic study feces including 16S rRNA sequencing, microbial transcriptomics metabolomics was performed cohort with varying phenotypes Several origin derived from...

10.1002/hep.32568 article EN cc-by-nc Hepatology 2022-05-13
Coming Soon ...